Skip to main content

Tenet Healthcare Corp

THC
Exchange
NYSE
Industry
Services-General Medical & Surgical Hospitals, NEC
SEC CIK
0000070318

In the last 90 days, Tenet Healthcare Corp insiders filed 0 open-market purchases and 7 sales; 688 institutions reported holding it in 13F filings for Q2 2026, worth $15.0B in total; Harris Associates (Oakmark) is the only superinvestor holding it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 30, 2026, 1:13 AM ET

Revenue flow, FY2025

Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Income statement

Each column is one fiscal year, newest first.

Income statement of Tenet Healthcare Corp, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
ReportedFeb 2, 2026Feb 12, 2025Feb 1, 2024Jan 19, 2023Jan 11, 2022
Revenue$21.3B$20.7B$20.5B$19.2B$19.5B
Operating income$3.51B$5.96B$2.51B$2.33B$2.87B
Interest expense––$901.0M$890.0M$923.0M
Income tax$433.0M$1.18B$306.0M$344.0M$411.0M
Net income$2.37B$4.06B$1.31B$1.00B$1.48B
EPS, basic$15.61$33.02$6.01$3.84$8.55
EPS, diluted$15.49$32.70$5.71$3.79$8.42
Weighted shares, basic90.2M96.9M101.6M106.9M106.8M
Weighted shares, diluted90.8M97.9M104.8M110.5M108.6M
Margins and growth
Operating margin16.5%28.8%12.2%12.2%14.7%
Net margin11.1%19.7%6.4%5.2%7.6%
Revenue growth, year over year+3.1%+0.6%+7.2%−1.6%+10.5%
Net income growth, year over year−41.8%+210.0%+31.0%−32.2%+92.2%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Tenet Healthcare Corp, annual
Line itemFY2025!FY2024!FY2023!FY2022!FY2021!
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
ReportedFeb 2, 2026Feb 12, 2025Feb 1, 2024Jan 19, 2023Jan 11, 2022
Cash and equivalents$2.88B$3.02B$1.23B$858.0M$2.36B
Accounts receivable$2.56B$2.54B$2.91B$2.94B$2.77B
Inventory$348.0M$346.0M$411.0M$405.0M$384.0M
Total current assets$7.85B$7.68B$7.17B$5.98B$7.08B
Goodwill$11.2B$10.7B$10.3B$10.1B$9.26B
Intangible assets$1.35B$1.40B$1.37B$1.42B$1.50B
Total assets$29.7B$28.9B$28.3B$27.2B$27.6B
Accounts payable$1.36B$1.29B$1.41B$1.50B$1.30B
Total current liabilities$4.46B$4.31B$4.76B$4.48B$5.11B
Total liabilities$20.7B$20.4B$22.8B$22.5B$23.3B
Shareholders' equity$6.02B$5.82B$3.12B$2.46B$2.05B

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Tenet Healthcare Corp, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
ReportedFeb 2, 2026Feb 12, 2025Feb 1, 2024Jan 19, 2023Jan 11, 2022
Operating cash flow$3.54B$2.05B$2.37B$1.08B$1.57B
Capital expenditures$1.01B$931.0M$751.0M$762.0M$658.0M
Free cash flow$2.53B$1.12B$1.62B$321.0M$910.0M
Depreciation and amortization$863.0M$818.0M$870.0M$841.0M$855.0M
Stock-based compensation$104.0M$67.0M$66.0M$56.0M$56.0M
Share buybacks$1.39B$672.0M$200.0M$250.0M–
Investing cash flow-$1.27B$3.43B-$969.0M-$808.0M-$714.0M
Financing cash flow-$2.40B-$3.69B-$1.03B-$1.78B-$936.0M
Net change in cash-$136.0M$1.79B$370.0M-$1.51B-$82.0M
Ratio
Stock-based compensation, % of revenue0.5%0.3%0.3%0.3%0.3%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Tenet Healthcare Corp by cover date
Cover dateShares outstandingChange in a yearFiling
Oct 23, 202679.6M−9.4%SEC
Jul 24, 202680.5M−8.9%SEC
Apr 22, 202686.1M−7.3%SEC
Jan 30, 202687.0M−8.6%SEC
Oct 22, 202587.9M−7.6%SEC
Jul 18, 202588.4M−7.8%SEC
Apr 18, 202592.9M−4.9%SEC
Jan 31, 202595.1M−4.9%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
  • A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.